-
641por Mooney, John D, Weir, Amanda, McMenamin, Jim, Ritchie, Lewis D, Macfarlane, Tatania V, Simpson, Colin R, Ahmed, Syed, Robertson, Chris, Clarke, Stuart C“…Based on the preceding four winter seasons, standardised incidence ratios (SIR) for invasive pneumococcal disease were determined by age-band and sex during winter 2003/2004. …”
Publicado 2008
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
642por Feikin, Daniel R, Jagero, Geoffrey, Aura, Barrack, Bigogo, Godfrey M, Oundo, Joseph, Beall, Bernard W, Karani, Angela, Morpeth, Susan, Njenga, M Kariuki, Breiman, Robert F“…BACKGROUND: Although causing substantial morbidity, the burden of pneumococcal disease among older children and adults in Africa, particularly in rural settings, is not well-characterized. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
643por Cheng, Aristine, Chang, Sui-Yuan, Tsai, Mao-Song, Su, Yi-Ching, Liu, Wen-Chun, Sun, Hsin-Yun, Hung, Chien-Ching“…Only one patient in the one-dose group had documented pneumococcal pneumonia (non-bacteraemic) and none had invasive pneumococcal disease in the 6.5 years of follow-up. CONCLUSIONS: One or two doses of PCV7 achieve durable seroprotective responses in HIV-treated participants; however, two doses may be more robust than one dose in a larger study population or in real-world populations with less cART coverage.…”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
644por Ndlangisa, Kedibone M., du Plessis, Mignon, Allam, Mushal, Wolter, Nicole, Mohale, Thabo, de Gouveia, Linda, Birkhead, Monica, Klugman, Keith P., von Gottberg, Anne“…Thus there are limited data describing cases of pneumococcal disease caused by more than one isolate. RESULTS: In two cases of invasive pneumococcal disease in South Africa, a non-serotypeable and a serotypeable isolate were co-detected during routine serotyping. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
645por Vissink, Conrad E., Huijts, Susanne M., de Wit, G. Ardine, Bonten, Marc J. M., Mangen, Marie-Josée J.“…Higher CURB-65 score and individuals at medium risk for developing pneumococcal disease were significantly associated with higher costs. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
646por Farkouh, Raymond, Nevo, Arianna, Uyei, Jennifer, Althouse, Benjamin, Hall-Murray, Cassandra, Lewnard, Joseph, Wasserman, Matthew“…We considered impact of PCVs on pneumococcal disease (PD) specifically related to clinical management of AMR-PD, including AMR epidemiology, antibiotic prescribing patterns, and healthcare resource utilization. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
647por Makenga, Geofrey, Mtove, George, Yin, J. Kevin, Mziray, Abubakary, Bwana, Veneranda M., Kisinza, William, Mjema, Julius, Amos, Ben, Antony, Laura, Shingadia, Delane, Oftadeh, Shahin, Booy, Robert“…In every year, up to one million children die due to pneumococcal disease. Children infected with Human Immunodeficiency Virus (HIV) are mostly affected, as they appear to have higher rates of pneumococcal carriage and invasive disease. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
648“…INTRODUCTION: Despite the availability of vaccines, pneumococcal disease (PD) is associated with high clinical and economic burden, mainly caused by non-vaccine serotypes and certain vaccine-type serotypes. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
649por Arends, Daan W., Alkema, Wynand, Hapsari Putri, Indri, van der Gaast–de Jongh, Christa E., Eleveld, Marc, Langereis, Jeroen D., de Mast, Quirijn, Meis, Jacques F., de Jonge, Marien I., Cremers, Amelieke J. H.“…Such knowledge could lead to more tailored vaccine targets or therapeutic approaches to reduce the million deaths that are caused by pneumococcal disease every year.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
650por Essink, Brandon, Sabharwal, Charu, Cannon, Kevin, Frenck, Robert, Lal, Himal, Xu, Xia, Sundaraiyer, Vani, Peng, Yahong, Moyer, Lisa, Pride, Michael W, Scully, Ingrid L, Jansen, Kathrin U, Gruber, William C, Scott, Daniel A, Watson, Wendy“…BACKGROUND: Pneumococcal conjugate vaccines (PCVs) have significantly reduced pneumococcal disease, but disease from non-PCV serotypes remains. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
651“…However, certain independent risk factors such as cigarette smoking and being of African-American (AA) decent have been associated with a higher incidence of invasive pneumococcal disease, but only cigarette smoking has been targeted by current recommendations from the Advisory Committee on Immunological Practices (ACIPs). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
652“…Recent EIP work has included monitoring the impact of a new conjugate vaccine on the epidemiology of invasive pneumococcal disease, providing the evidence base used to derive new recommendations to prevent neonatal group B streptococcal disease, measuring the impact of foodborne diseases in the United States, and developing a systematic, integrated laboratory and epidemiologic method for syndrome-based surveillance.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
653“…The herd effect has had a major impact in the eradication of smallpox, has reduced transmission of pertussis, and protects against influenza and pneumococcal disease. A high uptake of vaccines is generally needed for success. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
654por Glennie, Sarah J., Banda, Dominic, Mulwafu, Wakisa, Nkhata, Rose, Williams, Neil A., Heyderman, Robert S.“…Worldwide, invasive pneumococcal disease caused by Streptococcus pneumoniae is most common in young children. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
655“…While nephrotic syndrome is a well-known risk factor for invasive pneumococcal disease, this is the first reported case of pHUS in an adolescent patient with nephrotic syndrome, and reveals novel challenges in the diagnosis, treatment and potential prevention of this complication.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
656“…One reported case of severe invasive pneumococcal disease in a 68 year old female, that presented with Austrian’s triad of meningitis, pneumonia and endocarditis, and progressed to develop Guillain Barre syndrome, an association never been documented before. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
657por Zavala, Agustín, Kovacec, Verónica, Levín, Gustavo, Moglioni, Albertina, Miranda, María Victoria, García, Ernesto, Bonofiglio, Laura, Mollerach, Marta“…Since the eukaryotic enzymes are completely unrelated to their prokaryotic counterparts, we propose that the GalU enzyme is a critical target to fight the pneumococcal disease. A recombinant GalU(Spn) was overexpressed and purified. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
658“…Evidence from seven countries (Denmark, France, Greece, Portugal, Sweden, UK, US) shows limited or no effectiveness of the 13-valent pneumococcal conjugate vaccine against serotype 3 invasive pneumococcal disease and carriage. The serotype 3 capsule has some unique characteristics that may serve to explain this lack of efficacy—capsular polysaccharide is abundantly expressed, leading to a greater thickness of capsule, and free capsular polysaccharide may be released during growth. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
659por Dernoncourt, Amandine, El Samad, Youssef, Schmidt, Jean, Emond, Jean Philippe, Gouraud, Charlotte, Brocard, Anne, El Hamri, Mohamed, Plassart, Claire, Rousseau, Florence, Salle, Valéry, Diouf, Momar, Varon, Emmanuelle, Hamdad, Farida“…Among 1,062 cases of invasive pneumococcal disease, we observed 16 (1.5%) SA cases. Although SA is uncommon in adult patients, the prevalence of pneumococcal SA in the Picardie region increased from 0.69% during 2005–2010 to 2.47% during 2011–2016 after introduction of the pneumococcal 13-valent conjugate vaccine. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
660“…Pneumolysin (PLY) is a cholesterol-dependent cytolysin (CDC) and key pneumococcal virulence factor involved in all phases of pneumococcal disease, including transmission, colonization, and infection. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto